4 assets in Vascular Disorder

Therapeutic assets addressing Vascular Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Calcined Magnesia Vascular Disorder	Coordinación de Investigación en Salud, Mexico	P3	BB (64)
Triticum Aestivum Vascular Disorder	Coordinación de Investigación en Salud, Mexico	P3	BB (64)
Empagliflozin Vascular Disorder	VA Office of Research and Development	P2	CCC (53)
Kln-1010 Vascular Disorder	Kelonia Therapeutics, Inc.	P1	CC (43)